Copyright
©The Author(s) 2019.
World J Clin Cases. Feb 6, 2019; 7(3): 260-269
Published online Feb 6, 2019. doi: 10.12998/wjcc.v7.i3.260
Published online Feb 6, 2019. doi: 10.12998/wjcc.v7.i3.260
Characteristics | n (%) |
mean age | 64.7 yr (range 38–92 yr)1 |
Male sex | 80%1 |
Stage | |
Stage I–IIA | 11 (11.8) |
Stage IIB–III | 56 (60.2) |
Stage IVA–IVB | 21 (22.6) |
Unknown | 5 (5.4) |
Grade | |
Grade I | 11 (11.8 ) |
Grade II | 32 (34.4 ) |
Grade III | 44 (47.3) |
Unknown | 6 (6.5 ) |
Radical surgery | 38 (40.9) |
Definitive oncological treatment | 5 (5.4) |
Palliative treatment | 50 (53.7) |
Cause of death2 | |
Esophageal carcinoma | 59 (85.5) |
Myocardial infarction | 2 (2.9) |
Pneumonia | 2 (2.9) |
Other type of carcinoma | 1 (1.4) |
Pulmonary embolism | 1 (1.4) |
Cerebral infarction | 1 (1.4) |
Unknown | 2 (2.9) |
- Citation: Söderström HK, Kauppi JT, Oksala N, Paavonen T, Krogerus L, Räsänen J, Rantanen T. Overexpression of HSP27 and HSP70 is associated with decreased survival among patients with esophageal adenocarcinoma. World J Clin Cases 2019; 7(3): 260-269
- URL: https://www.wjgnet.com/2307-8960/full/v7/i3/260.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v7.i3.260